Babbage: Another dose of good news
The Economist Podcasts
Following promising results from Pfizer and Moderna, why is a third vaccine, from Oxford University and AstraZeneca, so important in the fight against covid-19? Host Kenneth Cukier and The Economist’s health policy editor Natasha Loder investigate the different approaches to this immense challenge. And Nicholas Christakis, a doctor and network scientist at Yale University, explains how despite a vaccine the pandemic could change humanity for good.
Please subscribe to The Economist for full access to print, digital and audio editions:
www.economist.com/podcastoffer
See acast.com/privacy for privacy and opt-out information.
Next Episodes
Tigray area: Ethiopia’s deadly standoff @ The Economist Podcasts
📆 2020-11-25 12:09 / ⌛ 00:21:46
Money Talks: The money doctors @ The Economist Podcasts
📆 2020-11-24 19:11 / ⌛ 00:31:16
What funds we’ll have: green venture capital @ The Economist Podcasts
📆 2020-11-24 12:09 / ⌛ 00:22:05
Playing his Trump cards: Biden’s China policy @ The Economist Podcasts
📆 2020-11-23 12:07 / ⌛ 00:22:18
Editor’s Picks: November 23rd 2020 @ The Economist Podcasts
📆 2020-11-23 01:01 / ⌛ 00:20:04